CORRESP 1 filename1.htm nby20210405_corresp.htm

 

 

April 5, 2021

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:

NovaBay Pharmaceuticals, Inc. (the Company)

Form S-3, File No. 333-254744

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3, as amended by Amendment No. 1 to the Form S-3, to become effective as of 5:00 p.m. (Eastern time) on Wednesday, April 7, 2021, or as soon as practicable thereafter.

 

 

   

Very truly yours,

       
   

NovaBay Pharmaceuticals, Inc.

       
       
   

By:

    /s/ Justin Hall

     

Justin Hall

     

Chief Executive Officer and General Counsel

cc:

Abby E. Brown, Squire Patton Boggs (US) LLP